For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Coping with Omicron: First, normalise the situation as being a stressful one
Coping with Omicron: First, normalise the situation as being a stressful one

Constant media saturation over the past two years has painted a catastrophic picture of COVID-19. Psychiatrist David Codyre explains that while this has been helpful in driving up immunisation rates, now that we are ‘learning to live with’ the virus, it is having unintended consequences
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Kurcer MA, Erdogan Z, Cakir Kardes V. The effect of the COVID-19 pandemic on health anxiety and cyberchondria levels of university students. Perspect Psychiatr Care 2022;58(1):132–40.
2. Heinen A, Varghese S, Krayem A, et al. Understanding health anxiety in the COVID-19 pandemic. Int J Soc Psychiatry 2021; 25 November online.